Authors: Sun Gongpeng, Yi Zuohuizi, Liu Juejun, Chen Changzheng DOI: 10.3760/cma.j.cn115989-20200926-00667 Published 2023-02-10 Cite as Chin J Exp Ophthalmol, 2023, 41(2): 160-165. Abstract [Download PDF] [Read Full Text] Objective To observe the choroidal vascular changes of chronic central serous chorioretinopathy (cCSC), and analyze […]
Tag: Central macular thickness
Efficacy and safety of conbercept for choroidal neovascularization secondary to chronic central serous chorioretinopathy
Auhtors: Mao Jianbo, Zhang Caiyun, Shen Lijun, Lao Jimeng, Shao Yirun, Wu Hanfei, Chen Yiqi, Tao Jiwei DOI: 10.3760/cma.j.cn115989-20201104-00742 Published 2021-01-10 Cite as Chin J Exp Ophthalmol, 2021,39(01): 42-46. Abstract [View PDF] [Read Full Text] Objective To evaluate the efficacy and […]
Clinical safety and efficacy of conbercept intravitreal injection on high myopic choroidal neovascularization
Authors: Jiao Mingfei, Li Xiaorong DOI: 10.3760/cma.j.issn.2095-0160.2016.08.013 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 725-728. Abstract [Download PDF] [Read Full Text] Background choroidal neovascularization (CNV) is the common reason of visual acuity impairment in high myopia patients, which usually leads to irreversible central visual impairment. […]